Clinical Trial Update: EGFR-IL12-CART Cells for Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating EGFR-IL12-CART cells in metastatic colorectal cancer. The study is sponsored by Shenzhen Second People's Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• EGFR-IL12-CART Cells

Snippet

Sponsor: Shenzhen Second People's Hospital | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: UNKNOWN